Resmed (RMD) Other Non-Current Liabilities (2010 - 2026)

Resmed's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $146.1 million for Q1 2026.

• Quarterly Other Non-Current Liabilities rose 198.22% year-over-year to $146.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $146.1 million (up 198.22% YoY) and the FY2025 annual result came in at $141.5 million, changed N/A from the prior year.
• Other Non-Current Liabilities was $146.1 million for Q1 2026 at Resmed, up from $138.5 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $146.1 million in Q1 2026 and bottomed at $5.1 million in Q1 2022.
• A 5-year average of $64.5 million and a median of $49.8 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities tumbled 90.51% — and 2023, when it soared 1262.98%.
• Resmed's Other Non-Current Liabilities stood at $50.6 million in 2022, then surged by 44.05% to $72.9 million in 2023, then sank by 85.14% to $10.8 million in 2024, then soared by 1179.09% to $138.5 million in 2025, then advanced by 5.44% to $146.1 million in 2026.
• Business Quant data shows RMD's Other Non-Current Liabilities at $146.1 million in Q1 2026, $138.5 million in Q4 2025, and $138.2 million in Q3 2025.